Indeed we have observed in case reports that non-responding metastatic do not have molecular expression of the primary site (EGFR, ALK, ROS1, ALK or PD-L1) or there are cases where we have a different lung cancer or lung cancer transformation 34-36. This evidence concerns the gene ROS1 and lung cancer.